Ovoca Bio plc
("Ovoca" or the "Company")
Holding(s) in Company
Dublin, Ireland, October 11, 2024 - Ovoca Bio, a biopharmaceutical company with a focus on women's health, has received notification from Mr. Timothy McCutcheon that, as of 9 October 2014, he holds an interest in 19,506,203 Ordinary Shares of nominal value €0.125 each, which represents approximately 22.05% of the Company's issued share capital. This percentage shareholding is based on the latest shares in issue figure of 88,458,806 ordinary shares of nominal value €0.125 each following the Company's recent sale of ordinary shares from treasury, as announced on 9 October 2024.
End
For further information:
Ovoca Bio plc
Tim McCutcheon (Chief Executive Officer)
Tel +353 1 661 9819
info@ovocabio.com
Davy (Nominated Adviser, Euronext Growth Listing Sponsor and Broker)
Ivan Murphy / Daragh O'Reilly
Tel: +353 1 679 6363
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
